Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 2, 1998, Pages 90-98

  Tanaka, Seigo ^a   Kawamata, Jun ^a   Shimohama, Shun ^a   Akaki, Hiroshi ^b   Akiguchi, Ichiro ^a   Kimura, Jun ^a   Ueda, Kunihiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Narabigaoka Hospital   (Japan)

Author keywords

Alzheimer's disease; Amygdala; Apolipoprotein E gene; Hippocampus; Magnetic resonance imaging; Temporal lobe; X ray computed tomography; Xe 133 SPECT

Indexed keywords

APOLIPOPROTEIN E; XENON 133;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GENOTYPE; HIPPOCAMPUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 0031891589     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017029     Document Type: Article

References (43)

1. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
2. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-166.
3. Wisniewski T, Frangione B: Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
4. Das HK, McPherson J, Bruns GAP, Karathanasis SK, Breslow JL: Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-6247.
5. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung W-Y, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NL, Heyman A, Clark CM, Roses AD: Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
6. Yu C-E, Payami H, Olson JM, Boehnke M, Wijsman EM, Orr HT, Kukull WA, Goddard KAB, Nemens E, White JA, Alonso ME, Taylor TD, Ball MJ, Kaye J, Morris J, Chui H, Sadovnick AD, Martin GM, Larson EB, Heston LL, Bird TD, Schellenberg GD: The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994;54:631-642.
7. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-1472.
8. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90: 1977-1981.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
10. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K: A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993;163:166-168.
11. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J: Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416.
12. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
13. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 8098-8102.
14. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong L-M, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
15. Barron SA, Jacobs L, Kinkel WR: Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology 1976;26:1011-1013.
16. Gado M, Hughes CP, Danziger W, Chi D, Jost G, Berg L: Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls. Radiology 1982;144:535-538.
17. George AE, De Leon MJ, Rosenbloom S, Ferris SH, Gentes C, Emmerich M, Kricheff II: Ventricular volume and cognitive deficit: A computed tomographic study. Radiology 1983;149: 493-498.
18. Creasey H, Schwartz M, Frederickson H, Haxby JV, Rapoport SI: Quantitative computed tomography in dementia of the Alzheimer type. Neurology 1986;36:1563-1568.
19. Kesslak JP, Nalcioglu O, Cotman CW: Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
20. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG: MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
21. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F: Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
22. Frisoni GB, Beltramello A, Weiss C, Geroldi C, Bianchetti A, Trabucchi M: Usefulness of simple measures of temporal lobe atrophy in probable Alzheimer's disease. Dementia 1996;7: 15-22.
23. Horn R, Ostertun B, Fric M, Solymosi L, Steudel A, Moller HJ: Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment. Dementia 1996;7:182-186.
24. Cuenod C-A, Denys A, Michot J-L, Jehenson P, Forette F, Kaplan D, Syrota A, Boller F: Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
25. Maunoury C, Michot JL, Caillet H, Parlato V, Leroy-Willig A, Jehenson P, Syrota A, Boller F: Specificity of temporal amygdala atrophy in Alzheimer's disease: Quantitative assessment with magnetic resonance imaging. Dementia 1996;7:10-14.
26. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL: Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol 1987;44:165-168.
27. Johnson KA, Holman BL, Mueller SP, Rosen TJ, English R, Nagel JS, Growdon JH: Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. Arch Neurol 1988;45:392-396.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
29. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
30. Heyman A, Wilkinson WE, Hurwitz BJ, Helms MJ, Haynes CS, Utley CM, Gwyther LP: Early-onset Alzheimer's disease: Clinical predictors of institutionalization and death. Neurology 1987;37:980-984.
31. Hosokawa T, Yamada Y, Isagoda A, Nakamura R: Psychometric equivalence of the Hasegawa dementia scale - revised with the mini-mental state examination in stroke patients. Percept Mot Skills 1994;79:664-666.
32. Okuizumi K, Onodera O, Tanaka H, Kobayashi H, Tsuji S, Takahashi H, Oyanagi K, Seki K, Tanaka M, Naruse S, Miyatake T, Mizusawa H, Kanazawa I: ApoE-ε4 and early-onset Alzheimer's. Nat Genet 1994;7:10-11.
33. Van Duijn CM, De Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
34. Corder EH, Saunders AM, Risen NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-183.
35. Ball MJ: Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. Acta Neuropathol (Berl) 1977;37:111-118.
36. Beaurain J, Dormont D, Semah F, Hasboun D, Baulac M: Hippocampal formation imaging with axial sections parallel to their longitudinal axis. Magn Reson Imaging 1994;12:139-148.
37. Von Cramon DY, Hebel N, Schuri U: Verbal memory and learning in unilateral posterior cerebral infarction. A report on 30 cases. Brain 1988;111:1061-1077.
38. Bugiani O, Constantinidis J, Ghetti B, Bouras C, Tagliavini F: Asymmetrical cerebral atrophy in Alzheimer's disease. Clin Neuropathol 1991; 10:55-60.
39. Lehtovirta M, Laakso MP, Soininen H, Helisaimi S, Mannermaa A, Helkala E-L, Partanen K, Ryynanen M, Vainio P, Hartikainen P, Riekkinen PJ Sr: Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72.
40. Lehtovirta M, Soininen H, Laakso MP, Partanen K, Helisalmi S, Mannermaa A, Ryynanen M, Kuikka J, Hartikainen P, Riekkinen PJ Sr: SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E ε4 allele. J Neurol Neurosurg Psychiatry 1996;60:644-649.
41. Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, Alavi J, Reivich M: Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 1987;28:1667-1670.
42. Frackowiak RSJ, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, Jones T: Regional cerebral oxygen supply and utilization in dementia. Brain 1981;104:753-778.
43. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, Guze BH, Corder EH, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942-947.